@izi

Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS

, , , , , , , , , , , , and . Journal of neuroinflammation, 20 (1): 106--106 (May 2023)
DOI: 10.1186/s12974-023-02785-y

Links and resources

Tags

community